Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy · Delayed Price · Currency is EUR 53.25
+0.20 (0.38%)
Nov 6, 2026, 5:35 PM CET
BIT:REC Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,705 | 2,618 | 2,342 | 2,082 | 1,853 | 1,580 |
Revenue Growth | 9.10% | 11.82% | 12.45% | 12.36% | 17.29% | 9.06% |
Gross Profit Gross Profit Growth | 1,934 | 1,854 | 1,638 | 1,482 | 1,336 | 1,152 |
Operating Income Operating Income Growth | 824.34 | 784.25 | 698.36 | 626.56 | 544.47 | 504.55 |
Net Income Net Income Growth | 497.18 | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 |
Earnings Per Share EPS Growth | 2.38 | 2.12 | 1.99 | 1.86 | 1.49 | 1.85 |
EPS Growth | 22.23% | 6.48% | 7.04% | 24.57% | -19.07% | 8.72% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Specialty & Primary Care Specialty & Primary Care Growth | 1,502 | 1,537 | 1,508 | 1,368 | 1,258 | 1,196 |
Rare Diseases Rare Diseases Growth | 1,170 | 1,081 | 833.86 | 714.72 | 595.79 | 383.85 |
Revenue (Total) Revenue (Total) Growth | 2,705 | 2,618 | 2,342 | 2,082 | 1,853 | 1,580 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 391.38 | 428.82 | 322.42 | 221.81 | 284.73 | 244.58 |
Total Debt Total Debt Growth | 2,314 | 2,472 | 2,490 | 1,829 | 1,734 | 1,006 |
Net Cash (Debt) Net Cash Growth | -1,922 | -2,044 | -2,168 | -1,607 | -1,449 | -761.77 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.20 | -9.77 | -10.37 | -7.68 | -6.93 | -3.64 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 644.69 | 596.9 | 569.92 | 485.32 | 461.69 | 491.65 |
Capital Expenditures CapEx Growth | -44.83 | -39.44 | -36.65 | -29.69 | -23.89 | -21.85 |
Free Cash Flow Free Cash Flow Growth | 599.86 | 557.45 | 533.27 | 455.63 | 437.8 | 469.8 |
Free Cash Flow Growth | 12.31% | 4.54% | 17.04% | 4.07% | -6.81% | 22.88% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.48% | 70.82% | 69.94% | 71.15% | 72.11% | 72.93% |
Operating Margin | 30.47% | 29.95% | 29.83% | 30.09% | 29.38% | 31.93% |
Pretax Margin | 24.35% | 22.20% | 23.37% | 23.58% | 21.66% | 29.32% |
Profit Margin | 18.38% | 16.94% | 17.79% | 18.69% | 16.85% | 24.43% |
FCF Margin | 22.17% | 21.29% | 22.77% | 21.88% | 23.62% | 29.73% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.340 | 1.340 | 1.270 | 1.200 | 1.150 | 1.100 |
Dividend Per Share Growth | 5.51% | 5.51% | 5.83% | 4.35% | 4.54% | 4.76% |
Dividend Yield | 2.52% | 2.76% | 2.53% | 2.46% | 2.97% | 1.94% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.38 | 22.38 | 24.84 | 25.80 | 25.48 | 30.20 |
Forward PE | 19.36 | 19.36 | 20.92 | 22.69 | 20.55 | 28.63 |
P/FCF Ratio | 18.08 | 17.81 | 19.40 | 22.04 | 18.18 | 24.81 |
PS Ratio | 4.01 | 3.79 | 4.42 | 4.82 | 4.30 | 7.38 |